About Event
The Future of Cell Therapy
The 8th CAR-TCR Summit Europe returns to London this February as the industry's most comprehensive European forum to advance next-generation cell therapy innovation. We're uniting 300+ experts and opinion leaders to exclusively showcase the hottest innovation across the cell therapy value chain, with the shared mission to consistently develop complex therapies that achieve durable responses in a time and cost-efficient manner.
Unmissable Highlights at the 8th CAR-TCR Summit Europe:
Address safety concerns with autoimmune indications and selecting the disease with the highest durability to reduce toxicity and improve efficacy with Cabaletta Bio
Break down the barriers and improve regulatory engagement and communication to tailor guidelines and gain regulatory support with Sana Biotechnology
Understand novel engineering technologies such as gene editing and armouring to improve durability and persistence with T-knife Therapeutics
Explore the differences in manufacturing processes for novel cell types to improve robustness of process and finetune manufacturing conditions with Eli Lilly
Gain a holistic understanding of the cancer environment using multiple tumour models to improve patient selection and clinical trial success with Kite, A Gilead Company
Divide & Conquer with Your Team to Maximise Takeaways:
Whether you work in discovery, clinical development, or process development, you can expect to meet colleagues working in the same field as you. With three tracks of carefully curated scientific content, this summit caters to industry leaders working across the breadth and depth of cell therapy innovation.
Here’s a snapshot:
Discovery
Uncover novel engineering approaches and targets to improve cell fitness, durability and potency
Connect with R&D Specialists, CSOs, CEOs, Preclinical Development Scientists, Heads, VPs and Directors of Research, and Biology
Clinical Development
Showcase translational learnings and best-practice for trial design to ensure successful, and cost-efficient trials
Meet VPs and Heads of Clinical Development, Clinical Trial Leads, Global Heads of Immunology, and Heads of Translational Biology
CMC, Process & Analytics
Advance manufacturability, quality control and engineering of complex cell therapies in early development
Catering to Heads of Process Development, Analytical Development Scientists, VPs of Global Manufacturing, Quality Control Leads, MSAT Scientists and VPs of quality Control
